Learn, listen, and watch the latest on transparency
From price transparency legislation to executive financial strategy, our team of experts is here to walk you through it all
Blogs
Catch up on the latest developments
2025 Transparency in Coverage proposed rule released
If finalized, payer MRFs are going to come out trimmer and more organized in 2027.
A year inside managed care's contract filing cabinet, reviewed
We’re going to need a bigger Swiffer
Unpacking the specifics of the CY 2026 final rule
Specifically unpacking the hospital price transparency section. The full final rule is 1,657 pages, so that's for a rainy day.
2026 OPPS final rule released; changes to come for hospital MRFs
OOPS, CMS did it again with a new OPPS Final Rule; enforcement delayed to 4/1/26
No results found
There are no results with this criteria. Try changing your search.
Reports
Dig deep or go wide on a topic
2025 drug reimbursement trends report
Turquoise Health and ZS's 2025 drug reimbursement trends report analyzes millions of hospital and payer-reported drug rates across 17 products and 4 therapeutic areas revealing how payer-provider dynamics drive reimbursement from 3× to 10× ASP. Explore the data.
Turquoise's public comment on CMS hospital price transparency accuracy and completeness RFI
Turquoise Health's full response to the CMS hospital price transparency accuracy & completeness RFI defining accuracy and completeness of MRF data and recommending how CMS should enforce meaningful compliance going forward. Read our full analysis.
Turquoise's public comment on CMS-9882-NC
Turquoise Health's public comment on CMS-9882-NC supporting the expansion of price transparency to include prescription drugs and making the case for comprehensive drug rate disclosure as critical healthcare infrastructure. Read our full analysis.
Webinars
Engage with your peers, virtually
Behind the report: 2025 drug reimbursement trends explained live
Turquoise Health and ZS unpack the 2025 drug reimbursement trends report live — explaining why some providers are reimbursed at 1–2× ASP and others at 10×, and what manufacturers can do with price transparency data to anticipate and respond to reimbursement dynamics. Explore the data.
How device manufacturers can leverage price transparency data ft. Boston Scientific
Boston Scientific joins Turquoise Health to show device manufacturers how to turn public price transparency files into a competitive advantage — finding negotiated rates, addressing data quality challenges, and building decision-ready reimbursement insights. See it in action.
Lessons from building an AI-driven contracting platform
Turquoise Health CEO Chris Severn and CTO Adam Geitgey share what they learned building a real AI-driven contracting platform used by major health systems — what worked, what didn't, and what AI can actually fix in managed care contract administration today. See it in action.
The past, present, and future of drug rates
Turquoise's Wayne Laun and Chris O'Dell trace how price transparency legislation has reshaped drug reimbursement — covering how providers and manufacturers are using drug rate data today, and what the latest executive order means for drug price transparency going forward. Explore the data.
Customer case studies
Hear directly from your peers across the industry
Innovu turns price transparency data into employer-ready network insights with Turquoise
Innovu integrated Turquoise's normalized rate data into its employer analytics platform, pairing paid claims with posted rates for the first time, moving from incomplete repricing exercises to confident in-platform answers, and expanding its reporting library for advisors and self-insured employers.
How Turquoise powers NYC’s health care price comparison tool
New Yorkers can now search, compare, and get an estimate before they even make an appointment. This groundbreaking tool is the first of its kind, but why did it take so long?
Recor Medical turns reimbursement data into patient access for renal denervation
Recor Medical equipped its field and market access teams with facility-level contracted rate data through Turquoise, replacing directional estimates, re-opening stalled provider conversations, and enabling smarter territory prioritization for a newly FDA-approved renal denervation therapy.
UNC Health modernizes its managed care contracting strategy with Turquoise
UNC Health replaced a fragmented, paper-based contract process with Turquoise's platform — saving ~$2M in a single negotiation, cutting contract merger analysis from two weeks to one day, and giving a team of 40 the competitive rate intelligence they needed to negotiate from a position of knowledge.
Loma Linda University Health transforms contract management with Turquoise
Loma Linda University Health replaced a manual, paper-based contract process with Turquoise's AI-powered platform, reducing contract question response time from hours to minutes and increasing their team's productivity by ~10%.
